| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-10 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.39 | 3e-08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |